Phase I study of epitope peptides with UFT/UZEL for unresectable colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Vaccination using epitope peptide from RNF43 and TOMM34
Primary outcome(s): safety
Study Design: Single arm Non-randomized
DISEASE(S): Unresectable Colorectal Cancer
PROVIDER: 2619184 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA